Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 384

1.

Oral contraceptives and survival in breast cancer patients aged 20 to 54 years.

Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Moorman PG, Kaufman JS, Cai J, Porter PL, Brinton LA, Eley JW, Coates RJ.

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1822-7.

2.

Breast cancer among young U.S. women in relation to oral contraceptive use.

White E, Malone KE, Weiss NS, Daling JR.

J Natl Cancer Inst. 1994 Apr 6;86(7):505-14.

PMID:
8133534
3.

Weighing the evidence on the pill and breast cancer.

Johnson JH.

Fam Plann Perspect. 1989 Mar-Apr;21(2):89-92. Review.

PMID:
2653859
4.
5.

Oral contraceptives and breast cancer.

Brinton LA, Hoover R, Szklo M, Fraumeni JF Jr.

Int J Epidemiol. 1982 Dec;11(4):316-22.

PMID:
7152784
6.

Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.

Gammon MD, Hibshoosh H, Terry MB, Bose S, Schoenberg JB, Brinton LA, Bernstein JL, Thompson WD.

Cancer Epidemiol Biomarkers Prev. 1999 May;8(5):413-9.

7.

Modification of oral contraceptive relationships on breast cancer risk by selected factors among younger women.

Brinton LA, Gammon MD, Malone KE, Schoenberg JB, Daling JR, Coates RJ.

Contraception. 1997 Apr;55(4):197-203.

PMID:
9179450
8.

Oral contraceptives and breast cancer.

Jick H, Walker AM, Watkins RN, D'Ewart DC, Hunter JR, Danford A, Madsen S, Dinan BJ, Rothman KJ.

Am J Epidemiol. 1980 Nov;112(5):577-85.

PMID:
7435486
9.

Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.

Vessey MP, Villard-Mackintosh L, McPherson K, Yeates D.

BMJ. 1989 Dec 16;299(6714):1487-91.

10.

Oral contraceptives and the risk of death from breast cancer.

Wingo PA, Austin H, Marchbanks PA, Whiteman MK, Hsia J, Mandel MG, Peterson HB, Ory HW.

Obstet Gynecol. 2007 Oct;110(4):793-800. Erratum in: Obstet Gynecol. 2008 Feb;111(2 Pt 1):454.

PMID:
17906011
11.

Survival in breast cancer and age at start of oral contraceptive usage.

Ranstam J, Olsson H, Garne JP, Aspegren K, Janzon L.

Anticancer Res. 1991 Nov-Dec;11(6):2043-6.

PMID:
1776838
12.

Breast cancer and oral contraceptive use in Asian-American women.

Ursin G, Wu AH, Hoover RN, West DW, Nomura AM, Kolonel LN, Pike MC, Ziegler RG.

Am J Epidemiol. 1999 Sep 15;150(6):561-7.

13.

Oral contraceptives and breast cancer: latest findings in a large cohort study.

Vessey MP, McPherson K, Villard-Mackintosh L, Yeates D.

Br J Cancer. 1989 Apr;59(4):613-7.

14.

Age-specific differences in the relationship between oral contraceptive use and breast cancer.

Wingo PA, Lee NC, Ory HW, Beral V, Peterson HB, Rhodes P.

Cancer. 1993 Feb 15;71(4 Suppl):1506-17.

15.

Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.

Jernström H, Loman N, Johannsson OT, Borg A, Olsson H.

Eur J Cancer. 2005 Oct;41(15):2312-20. Epub 2005 Aug 22.

PMID:
16118051
16.

Oral contraceptive use and risk of colorectal cancer.

Fernandez E, La Vecchia C, Franceschi S, Braga C, Talamini R, Negri E, Parazzini F.

Epidemiology. 1998 May;9(3):295-300.

PMID:
9583422
17.

Breast cancer and oral contraceptive use.

Rosenberg L, Miller DR, Kaufman DW, Helmrich SP, Stolley PD, Schottenfeld D, Shapiro S.

Am J Epidemiol. 1984 Feb;119(2):167-76.

PMID:
6695896
18.

Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study.

Kumle M, Weiderpass E, Braaten T, Persson I, Adami HO, Lund E.

Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1375-81.

19.
20.

Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.

O'Meara ES, Rossing MA, Daling JR, Elmore JG, Barlow WE, Weiss NS.

J Natl Cancer Inst. 2001 May 16;93(10):754-62.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk